Xtant Medical Holdings, Inc.
XTNT
$0.54
-$0.01-1.47%
AMEX
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -2.70% | -6.09% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.70% | -6.09% | |||
| Cost of Revenue | 29.65% | 1.22% | |||
| Gross Profit | -19.27% | -9.44% | |||
| SG&A Expenses | -3.07% | -1.45% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.42% | -0.24% | |||
| Operating Income | -137.15% | -45.05% | |||
| Income Before Tax | 2.11% | -58.87% | |||
| Income Tax Expenses | 499.61% | 0.78% | |||
| Earnings from Continuing Operations | -95.64% | -63.15% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -95.64% | -63.15% | |||
| EBIT | -137.15% | -45.05% | |||
| EBITDA | -76.36% | -36.10% | |||
| EPS Basic | -95.74% | -63.14% | |||
| Normalized Basic EPS | -207.14% | -59.06% | |||
| EPS Diluted | -100.00% | -53.00% | |||
| Normalized Diluted EPS | -207.69% | -59.38% | |||
| Average Basic Shares Outstanding | 0.08% | 0.29% | |||
| Average Diluted Shares Outstanding | 0.06% | 1.21% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||